Investing in life saving science

Healthcare is at a tipping point with rising costs, but with more and increasingly older people to care for. We need better and more cost-effective ways to treat and manage patients. We deserve better health. Nordics and Baltics are epicenters of unparalleled science and world-class technology to solve current and future healthcare issues.

Our Life Science fund invests in early-stage biotech and digital health companies who are developing life-saving or life-altering products for unmet medical needs with global potential. We love science, and we want to make a big impact with the founders we team up with.


Targetsector

Biotech & Digital Health

Targetgeo

Nordics & Baltics

Targetstage

Pre-seed to Series-A

Fundsize

€90m

Initialticket size

€250k–€3m